Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169279953> ?p ?o ?g. }
- W2169279953 endingPage "1617" @default.
- W2169279953 startingPage "1612" @default.
- W2169279953 abstract "<h3>Objective</h3> Liver function test (LFT) elevations are reported with the use of tumour necrosis factor inhibitors (TNF-Is). The aim of this study was to compare LFT elevations in patients with rheumatoid arthritis receiving adalimumab (ADA), etanercept (ETN) or infliximab (INF) enrolled in the Consortium of Rheumatology Researchers of North America from October 2001 to March 2007. <h3>Methods</h3> Alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) levels >1× upper limit of normal (ULN) were considered elevations and ALT/AST levels >2× ULN were considered abnormalities. Treatments included TNF-Is, methotrexate (MTX), leflunomide and other disease-modifying antirheumatic agents (DMARDs). Patients were censored after their first LFT elevation. Three analytical models were evaluated: (1) individual TNF-I vs non-biological DMARDs (primary model); (2) individual TNF-I plus MTX vs MTX monotherapy; and (3) limited to new users of individual TNF-I vs non-biological DMARDs. ORs for LFT elevations were estimated using generalised estimating equation logistic regression. <h3>Results</h3> 6861 patients (ADA: 849; ETN: 1383; INF: 1449) with 22 522 determinations were analysed. LFT elevations >1× ULN with TNF-I use were seen in 5.9% of AST/ALT determinations and abnormalities >2× ULN in 0.77%. In the primary model the adjusted ORs for LFT elevations >1× ULN were ADA 1.35 (95% CI 1.09 to 1.66), ETN 1.00 (95% CI 0.83 to 1.21) and INF 1.58 (95% CI 1.35 to 1.86). For 2× ULN, adjusted ORs were ADA 1.72 (95% CI 0.99 to 3.01), ETN 1.10 (95% CI 0.64 to 1.88) and INF 2.40 (95% CI 1.53 to 3.76). Similar results were obtained in other models. <h3>Conclusion</h3> The overall incidence of LFT elevations >1× ULN with TNF-I use was uncommon and abnormalities >2× ULN were rarely observed. Significant differences were most consistently observed with INF, less commonly with ADA and were not observed with ETN compared with comparator DMARDs." @default.
- W2169279953 created "2016-06-24" @default.
- W2169279953 creator A5000754711 @default.
- W2169279953 creator A5004856138 @default.
- W2169279953 creator A5012283576 @default.
- W2169279953 creator A5014147030 @default.
- W2169279953 creator A5017122892 @default.
- W2169279953 creator A5030768494 @default.
- W2169279953 creator A5032801878 @default.
- W2169279953 creator A5046429545 @default.
- W2169279953 creator A5052078671 @default.
- W2169279953 creator A5056200498 @default.
- W2169279953 creator A5058110978 @default.
- W2169279953 creator A5082215179 @default.
- W2169279953 date "2010-05-06" @default.
- W2169279953 modified "2023-10-15" @default.
- W2169279953 title "Risk of elevated liver enzymes associated with TNF inhibitor utilisation in patients with rheumatoid arthritis" @default.
- W2169279953 cites W1772740936 @default.
- W2169279953 cites W1777614666 @default.
- W2169279953 cites W1965315521 @default.
- W2169279953 cites W1973564016 @default.
- W2169279953 cites W1990700997 @default.
- W2169279953 cites W1992574939 @default.
- W2169279953 cites W1997282832 @default.
- W2169279953 cites W1999663447 @default.
- W2169279953 cites W2024031781 @default.
- W2169279953 cites W2026865649 @default.
- W2169279953 cites W2030316260 @default.
- W2169279953 cites W2055280685 @default.
- W2169279953 cites W2079538137 @default.
- W2169279953 cites W2081424106 @default.
- W2169279953 cites W2086478005 @default.
- W2169279953 cites W2090993184 @default.
- W2169279953 cites W2097564087 @default.
- W2169279953 cites W2144511941 @default.
- W2169279953 cites W2151445773 @default.
- W2169279953 cites W2154976029 @default.
- W2169279953 cites W2168964138 @default.
- W2169279953 cites W271837667 @default.
- W2169279953 cites W86812204 @default.
- W2169279953 doi "https://doi.org/10.1136/ard.2009.112136" @default.
- W2169279953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20448284" @default.
- W2169279953 hasPublicationYear "2010" @default.
- W2169279953 type Work @default.
- W2169279953 sameAs 2169279953 @default.
- W2169279953 citedByCount "84" @default.
- W2169279953 countsByYear W21692799532012 @default.
- W2169279953 countsByYear W21692799532013 @default.
- W2169279953 countsByYear W21692799532014 @default.
- W2169279953 countsByYear W21692799532015 @default.
- W2169279953 countsByYear W21692799532016 @default.
- W2169279953 countsByYear W21692799532017 @default.
- W2169279953 countsByYear W21692799532018 @default.
- W2169279953 countsByYear W21692799532019 @default.
- W2169279953 countsByYear W21692799532020 @default.
- W2169279953 countsByYear W21692799532021 @default.
- W2169279953 countsByYear W21692799532022 @default.
- W2169279953 countsByYear W21692799532023 @default.
- W2169279953 crossrefType "journal-article" @default.
- W2169279953 hasAuthorship W2169279953A5000754711 @default.
- W2169279953 hasAuthorship W2169279953A5004856138 @default.
- W2169279953 hasAuthorship W2169279953A5012283576 @default.
- W2169279953 hasAuthorship W2169279953A5014147030 @default.
- W2169279953 hasAuthorship W2169279953A5017122892 @default.
- W2169279953 hasAuthorship W2169279953A5030768494 @default.
- W2169279953 hasAuthorship W2169279953A5032801878 @default.
- W2169279953 hasAuthorship W2169279953A5046429545 @default.
- W2169279953 hasAuthorship W2169279953A5052078671 @default.
- W2169279953 hasAuthorship W2169279953A5056200498 @default.
- W2169279953 hasAuthorship W2169279953A5058110978 @default.
- W2169279953 hasAuthorship W2169279953A5082215179 @default.
- W2169279953 hasConcept C126322002 @default.
- W2169279953 hasConcept C17991360 @default.
- W2169279953 hasConcept C198451711 @default.
- W2169279953 hasConcept C2775905006 @default.
- W2169279953 hasConcept C2777138892 @default.
- W2169279953 hasConcept C2777226972 @default.
- W2169279953 hasConcept C2777575956 @default.
- W2169279953 hasConcept C2778606649 @default.
- W2169279953 hasConcept C2779722408 @default.
- W2169279953 hasConcept C2780132546 @default.
- W2169279953 hasConcept C2781059491 @default.
- W2169279953 hasConcept C71924100 @default.
- W2169279953 hasConcept C90924648 @default.
- W2169279953 hasConceptScore W2169279953C126322002 @default.
- W2169279953 hasConceptScore W2169279953C17991360 @default.
- W2169279953 hasConceptScore W2169279953C198451711 @default.
- W2169279953 hasConceptScore W2169279953C2775905006 @default.
- W2169279953 hasConceptScore W2169279953C2777138892 @default.
- W2169279953 hasConceptScore W2169279953C2777226972 @default.
- W2169279953 hasConceptScore W2169279953C2777575956 @default.
- W2169279953 hasConceptScore W2169279953C2778606649 @default.
- W2169279953 hasConceptScore W2169279953C2779722408 @default.
- W2169279953 hasConceptScore W2169279953C2780132546 @default.
- W2169279953 hasConceptScore W2169279953C2781059491 @default.
- W2169279953 hasConceptScore W2169279953C71924100 @default.
- W2169279953 hasConceptScore W2169279953C90924648 @default.
- W2169279953 hasIssue "9" @default.